サンクト　ダイズイソフラボン

Registration number

K354

Type

Processed food (tablets, capsules and similar forms)

Published status

Sales suspended

Notifier

株式会社サンクト

Notification date

2025-09-29

Modification date

2026-09-12

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

• Conditions légales

  Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Information

  A claim declared in Japan is not an authorised health claim in the European Union.

  CAA, Japan Foods with Function Claims notifications, retrieval date unknown.

  Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

  Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

大豆抽出物含有加工食品

Declared claim (original Japanese text)

本品には、大豆イソフラボンが含まれます。大豆イソフラボンには骨の成分を維持するのに役立つ機能があることが報告されています。

Precautions (original Japanese text)

本品は、多量摂取により疾病が治癒したり、より健康が増進したりするものではありません。

Raw materials of functional ingredients (original Japanese text)

大豆抽出物

Recommended daily intake (original Japanese text)

2粒(400mg)

Method of consumption (original Japanese text)

1日2粒(400mg)を目安に、水またはぬるま湯と一緒にお召し上がりください。

Ingredient names for daily quantities (original Japanese text)

大豆イソフラボン

Declared daily quantities (original Japanese text)

23.3mg

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

Official source

View the official register, number K354

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

List in the official revision dated 12 September 2026 (register: CAA, Japan Foods with Function Claims notifications).

Has the product changed? Photograph the packaging.